Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.615 USD | +2.83% | -13.51% | +80.78% |
05-09 | Monopar Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-16 | Monopar Therapeutics Files Provisional Patent for New MNPR-101 Construct | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+80.78% | 10.44M | |
+31.50% | 49.46B | |
+1.14% | 42.58B | |
+49.00% | 42.49B | |
-5.26% | 29.09B | |
+12.54% | 26.61B | |
-23.64% | 18.64B | |
+7.47% | 13.16B | |
+30.97% | 12.55B | |
+23.72% | 12.1B |
- Stock Market
- Equities
- MNPR Stock
- News Monopar Therapeutics Inc.
- Monopar Therapeutics Files Provisional Patent for New MNPR-101 Construct